Prevalence of the metabolic syndrome and overweight among adults in China.
By D. Gu, K. Reynolds, Xi-gui Wu, Jing Chen, X. Duan, R. Reynolds, P. Whelton, Jiang He. The Lancet, 2005
955 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/ead1573e913c8932b03f940f47360d20be6e9afe
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
- Simin Liu
- Lorraine O'Driscoll
- Sadhbh O’Neill
- J. Despres
- Anoop Misra
- D. Mozaffarian
- L. Khurana
- S. Grundy
In Epidemiology
In Molecular Biology
Citations in the corpus
- The Global Burden of Liver Disease: The Major Impact of China (2014, background): “0) in women in China.(28) For children 10 years, the prevalence of MetS was 32.”
- Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association (2009, background): “For diabetic ketoacidosis, costs were $14 236 for youth with versus $8398 for youth without diabetic ketoacidosis.(79) ● The cost of hypoglycemia, according to data from 536 581 individuals with type 2 DM from the 2004 to 2008 MarketScan database, was $52 223 675, which accounted for 1.”
- Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies (2015, methodology): “(19) identified MetS in a Chinese population according to the NCEP:ATPIII definition.”
- Obesity and the metabolic syndrome in developing countries. (2008, background): “, 2005 (40) China 35–74 15540 NCEP, ATP III 9.”
- Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review (2017, background): “China [21, 28] 2000–2001; National; N – 15540; 35–74 years NCEP ATP III 13.”